ZNF234 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.687900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.160800E-01
Normal-vs-Stage2
5.685500E-02
Normal-vs-Stage3
7.778000E-02
Normal-vs-Stage4
6.552600E-01
Stage1-vs-Stage2
4.714000E-01
Stage1-vs-Stage3
3.561800E-02
Stage1-vs-Stage4
7.043000E-01
Stage2-vs-Stage3
1.303770E-01
Stage2-vs-Stage4
2.676200E-01
Stage3-vs-Stage4
1.334800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.830000E-02
Normal-vs-AfricanAmerican
2.097200E-01
Normal-vs-Asian
7.633800E-02
Caucasian-vs-AfricanAmerican
8.460800E-01
Caucasian-vs-Asian
5.485400E-01
AfricanAmerican-vs-Asian
5.534600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.965500E-02
Normal-vs-Female
3.562200E-02
Male-vs-Female
9.994200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.395200E-01
Normal-vs-Age(41-60Yrs)
1.855840E-01
Normal-vs-Age(61-80Yrs)
2.283800E-02
Normal-vs-Age(81-100Yrs)
5.361900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.679000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.419000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.708000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.961800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.574400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.217200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.423600E-02
Normal-vs-Daily Drinker
1.404340E-02
Normal-vs-Weekly Drinker
8.726100E-02
Normal-vs-Occasional Drinker
7.660100E-02
Normal-vs-Social Drinker
2.089600E-01
Non Drinker-vs-Daily Drinker
4.525600E-01
Non Drinker-vs-Weekly Drinker
9.776400E-01
Non Drinker-vs-Occasional Drinker
7.194200E-01
Non Drinker-vs-Social Drinker
2.313600E-01
Daily Drinker-vs-Weekly Drinker
4.418000E-01
Daily Drinker-vs-Occasional Drinker
2.129200E-01
Daily Drinker-vs-Social Drinker
2.932100E-02
Weekly Drinker-vs-Occasional Drinker
7.473600E-01
Weekly Drinker-vs-Social Drinker
2.452400E-01
Occasional Drinker-vs-Social Drinker
3.330000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.535990E-01
Normal-vs-Grade 2
3.712100E-02
Normal-vs-Grade 3
2.980300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.439800E-01
Grade 1-vs-Grade 3
1.227410E-01
Grade 1-vs-Grade 4
1.535990E-01
Grade 2-vs-Grade 3
1.797180E-01
Grade 2-vs-Grade 4
3.712100E-02
Grade 3-vs-Grade 4
2.980300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.453600E-02
Normal-vs-NonDiabetic
3.644300E-02
Diabetic-vs-NonDiabetic
2.397600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.009000E-01
Normal-vs-NoPancreatitis
2.806400E-02
Pancreatitis-vs-NoPancreatitis
5.775200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.622100E-02
Normal-vs-N1
5.466100E-02
N0-vs-N1
5.252600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.296400E-02
Normal-vs-TP53-NonMutant
1.268570E-01
TP53-Mutant-vs-TP53-NonMutant
7.054200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
